Kansas University Medical Center and iSage Rx Receive Blue Cross and Blue Shield of Kansas City (Blue KC) Outcomes Grant to Study Insulin Optimization Insulin-Dependent Patients Will Be Enrolled in Clinical Trial Using iSage’s FDA Cleared Insulin Titration Application WILMINGTON, Del., June 11, 2018 (GLOBE NEWSWIRE) -- The University of Kansas...

Amalgam Rx Partners with UCB on BEYOND™, a Digital Health Solution for Patients with Psoriasis and Psoriatic Arthritis WILMINGTON, Del., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Allay Rx, a subsidiary of Amalgam Rx, Inc., a leading digital therapeutics company, announced today a partnership on a comprehensive behavioral...

Amalgam Rx Unveils iSage Rx, the First FDA-Cleared Application for Titration of all Brands of Basal Insulin WILMINGTON, DE--(Marketwired - May 1, 2017) - Amalgam Rx, a new digital health company, today released iSage Rx, the first FDA 510(k)-cleared, prescription-only mobile application for the automated...

Digital Health Pioneers Launch New Company, Amalgam Rx, to Transform Patient Self-Management and Healthcare Provider Care Delivery WILMINGTON, DE--(Marketwired - May 1, 2017) - Amalgam Rx, Inc., a digital health company, launched today to develop next-generation, evidence-based digital therapies that empower and engage...